1. Efficacy and Safety of Tripterygium Wilfordii Hook. F for Connective Tissue Disease-Associated Interstitial Lung Disease:A Systematic Review and Meta-Analysis
   Yehui Li et al, 2021, Frontiers in Pharmacology CrossRef
2. A single-injection targeted metabolomics profiling method for determination of biomarkers to reflect tripterygium glycosides efficacy and toxicity
   Ting Hu et al, 2020, Toxicology and Applied Pharmacology CrossRef
3. Synchronous Investigation of the Mechanism and Substance Basis of Tripterygium Glycosides Tablets on Anti-rheumatoid Arthritis and Hepatotoxicity
   Qi Qian et al, 2022, Applied Biochemistry and Biotechnology CrossRef
4. Protective Effect and Possible Mechanisms of Tripterygium Glycosides in Patients with Ankylosing Spondylitis: A Systematic Review and Meta-Analysis
   Zhou Lin et al, 2022, Oxidative Medicine and Cellular Longevity CrossRef
5. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease
   Yuyang Wang et al, 2020, Journal of Diabetes Research CrossRef
6. Serum RANKL levels in Chinese patients with ankylosing spondylitis: a meta-analysis
   Feifei Ni et al, 2021, Journal of Orthopaedic Surgery and Research CrossRef
7. Immunoregulatory effects of Tripterygium wilfordii Hook F and its extracts in clinical practice
   Dan Luo et al, 2019, Frontiers of Medicine CrossRef
8. Combination therapy of tripterygium glycosides plus valsartan in diabetic nephropathy treatment: A systematic review and meta-analysis
   Wan-chun Ye et al, 2019, Chinese Herbal Medicines CrossRef
9. Tripterygium wilfordii: An inspiring resource for rheumatoid arthritis treatment
   Yanqiong Zhang et al, 2021, Medicinal Research Reviews CrossRef
10. Mechanism of action ofTripterygium wilfordiifor treatment of idiopathic membranous nephropathy based on network pharmacology
    Honghong Shi et al, 2022, Renal Failure CrossRef
11. Dickkopf-1 as a promising therapeutic target for autoimmune diseases
    Sha-Sha Tao et al, 2022, Clinical Immunology CrossRef
12. Triptolide alleviates the development of inflammation in ankylosing spondylitis via the NONHSAT227927.1/JAK2/STAT3 pathway
    Xiang Ding et al, 2023, Experimental and Therapeutic Medicine CrossRef
13. Associations of the VEGF level, VEGF rs2010963 G/C gene polymorphism and ankylosing spondylitis risk in a Chinese Han population
    Mingjie Wang et al, 2016, Immunology Letters CrossRef
14. Tripterygium wilfordii Inhibiting Angiogenesis for Rheumatoid Arthritis Treatment
    Weisan Zhang et al, 2017, Journal of the National Medical Association CrossRef
15. Multi-target mechanism of Tripteryguim wilfordii Hook for treatment of ankylosing spondylitis based on network pharmacology and molecular docking
    Jing Zhang et al, 2021, Annals of Medicine CrossRef